CO2017012845A2 - Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen - Google Patents
Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienenInfo
- Publication number
- CO2017012845A2 CO2017012845A2 CONC2017/0012845A CO2017012845A CO2017012845A2 CO 2017012845 A2 CO2017012845 A2 CO 2017012845A2 CO 2017012845 A CO2017012845 A CO 2017012845A CO 2017012845 A2 CO2017012845 A2 CO 2017012845A2
- Authority
- CO
- Colombia
- Prior art keywords
- acid derivatives
- hydroxy acid
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
La invención se refiere a nuevos derivados de hidroxiácido, a un proceso para su preparación y a composiciones farmacéuticas que los contienen. Particularmente, los derivados de hidroxiácido tienen la fórmula (I), en la que R1, R2, R3 , R4, R5, R6, R7, R8, R14, A y n son como se han definido en la descripción. Los compuestos de la presente invención tienen propiedades pro-apoptóticas lo que hace posible usarlos en patologías que implican un defecto en la apoptosis, tal como, por ejemplo, en el tratamiento del cáncer y de enfermedades inmunes y auto-inmunes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1555753A FR3037958B1 (fr) | 2015-06-23 | 2015-06-23 | Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/EP2016/064417 WO2016207216A1 (en) | 2015-06-23 | 2016-06-22 | New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2017012845A2 true CO2017012845A2 (es) | 2018-03-28 |
Family
ID=54260902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2017/0012845A CO2017012845A2 (es) | 2015-06-23 | 2017-12-14 | Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen |
Country Status (45)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3037957B1 (fr) * | 2015-06-23 | 2019-01-25 | Les Laboratoires Servier | Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3037956B1 (fr) * | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3037958B1 (fr) * | 2015-06-23 | 2019-01-25 | Les Laboratoires Servier | Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3037959B1 (fr) * | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| AU2017300738A1 (en) | 2016-07-22 | 2019-02-07 | Les Laboratoires Servier | Combination of a BCL-2 inhibitor and a MCL-1 inhibitor, uses and pharmaceutical compositions thereof |
| WO2018126898A1 (zh) * | 2017-01-05 | 2018-07-12 | 河南美泰宝生物制药有限公司 | 噻吩并嘧啶衍生物、其制备方法及在制备抗肿瘤药物中的应用 |
| GEP20227372B (en) * | 2017-01-06 | 2022-04-25 | Novartis Ag | Combination of a mcl-1 inhibitor and a taxane compound, uses and pharmaceutical compositions thereof |
| UY37560A (es) | 2017-01-06 | 2018-07-31 | Servier Lab | Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta |
| ES2971466T3 (es) * | 2017-06-22 | 2024-06-05 | Servier Lab | Combinación de un inhibidor de Mcl-1 y un tratamiento estándar de atención para cánceres hematológicos, usos y composiciones farmacéuticas de la misma |
| SG10202106345VA (en) | 2017-08-15 | 2021-07-29 | Abbvie Inc | Macrocyclic mcl-1 inhibitors and methods of use |
| BR112020003163A2 (pt) * | 2017-08-15 | 2020-09-15 | AbbVie Deutschland GmbH & Co. KG | inibidores macrocíclicos de mcl-1 e métodos de uso |
| CN111372936B (zh) * | 2017-11-23 | 2022-12-02 | 北京赛林泰医药技术有限公司 | Mcl-1选择性抑制剂及其制备和用途 |
| CN108424417B (zh) * | 2017-12-21 | 2019-09-20 | 河南真实生物科技有限公司 | 噻吩并嘧啶衍生物、其制备方法及在制备抗肿瘤药物中的应用 |
| AR116635A1 (es) | 2018-10-15 | 2021-05-26 | Servier Lab | Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen |
| TWI849001B (zh) | 2018-11-14 | 2024-07-21 | 法商施維雅藥廠 | Mcl-1抑制劑及米哚妥林(midostaurin)之組合，其用途及醫藥組合物 |
| UY38700A (es) * | 2019-05-20 | 2020-12-31 | Novartis Ag | Conjugados de anticuerpo-fármaco inhibidores de mcl-1 y sus métodos de uso |
| TW202114682A (zh) | 2019-06-17 | 2021-04-16 | 法商施維雅藥廠 | Mcl-1抑制劑與乳癌標準療法之組合，其用途及醫藥組合物 |
| CN113024577B (zh) * | 2019-12-09 | 2023-06-30 | 首药控股(北京)股份有限公司 | 一种抗凋亡蛋白选择性抑制剂的制备方法 |
| US20240042051A1 (en) | 2020-11-24 | 2024-02-08 | Francesca Rocchetti | Mcl-1 inhibitor antibody-drug conjugates and methods of use |
| WO2022261310A1 (en) | 2021-06-11 | 2022-12-15 | Gilead Sciences, Inc. | Combination mcl-1 inhibitors with anti-body drug conjugates |
| CN117651554A (zh) | 2021-06-11 | 2024-03-05 | 吉利德科学公司 | Mcl-1抑制剂与抗癌剂的组合 |
| WO2023225359A1 (en) | 2022-05-20 | 2023-11-23 | Novartis Ag | Antibody-drug conjugates of antineoplastic compounds and methods of use thereof |
| WO2025111450A1 (en) | 2023-11-22 | 2025-05-30 | Les Laboratoires Servier | Anti-cd74 antibody-drug conjugates and methods of use thereof |
| WO2025111431A1 (en) | 2023-11-22 | 2025-05-30 | Les Laboratoires Servier | Anti-cd7 antibody-drug conjugates and methods of use thereof |
| TW202530255A (zh) | 2023-12-15 | 2025-08-01 | 法商亞維西亞有限公司 | 抗ｉｌ－１ｒａｐ結合結構域及其抗體－藥物偶聯物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070213305A1 (en) * | 2005-11-02 | 2007-09-13 | Cytovia, Inc. | N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| CN101679313A (zh) * | 2007-04-13 | 2010-03-24 | 休普基因公司 | 用于治疗癌症或过度增殖性疾病的axl激酶抑制剂 |
| CN102464667B (zh) * | 2010-11-03 | 2014-06-04 | 中国科学院上海药物研究所 | 一类五元杂环并嘧啶类化合物及其制备方法和用途 |
| AR090037A1 (es) * | 2011-11-15 | 2014-10-15 | Xention Ltd | Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio |
| FR2986002B1 (fr) * | 2012-01-24 | 2014-02-21 | Servier Lab | Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3015483B1 (fr) * | 2013-12-23 | 2016-01-01 | Servier Lab | Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3037956B1 (fr) * | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3037959B1 (fr) * | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3037957B1 (fr) * | 2015-06-23 | 2019-01-25 | Les Laboratoires Servier | Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3037958B1 (fr) * | 2015-06-23 | 2019-01-25 | Les Laboratoires Servier | Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3046792B1 (fr) * | 2016-01-19 | 2018-02-02 | Les Laboratoires Servier | Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2015
- 2015-06-23 FR FR1555753A patent/FR3037958B1/fr not_active Expired - Fee Related
-
2016
- 2016-06-16 UY UY0001036735A patent/UY36735A/es active IP Right Grant
- 2016-06-22 BR BR112017027831A patent/BR112017027831A2/pt not_active Application Discontinuation
- 2016-06-22 DK DK16731155.4T patent/DK3313849T3/da active
- 2016-06-22 HR HRP20230472TT patent/HRP20230472T1/hr unknown
- 2016-06-22 KR KR1020187002026A patent/KR102620976B1/ko active Active
- 2016-06-22 PE PE2017002741A patent/PE20180949A1/es unknown
- 2016-06-22 JP JP2017566288A patent/JP6773695B2/ja active Active
- 2016-06-22 UA UAA201800619A patent/UA124759C2/uk unknown
- 2016-06-22 EP EP16731155.4A patent/EP3313849B8/en active Active
- 2016-06-22 SI SI201631700T patent/SI3313849T1/sl unknown
- 2016-06-22 MX MX2017017008A patent/MX385720B/es unknown
- 2016-06-22 TN TNP/2017/000529A patent/TN2017000529A1/en unknown
- 2016-06-22 JO JOP/2016/0129A patent/JO3807B1/ar active
- 2016-06-22 AU AU2016282827A patent/AU2016282827B2/en active Active
- 2016-06-22 WO PCT/EP2016/064417 patent/WO2016207216A1/en not_active Ceased
- 2016-06-22 MD MDE20180439T patent/MD3313849T2/ro unknown
- 2016-06-22 PT PT167311554T patent/PT3313849T/pt unknown
- 2016-06-22 US US15/738,601 patent/US10322131B2/en active Active
- 2016-06-22 CN CN201680048558.4A patent/CN107922432B/zh active Active
- 2016-06-22 HK HK18113626.5A patent/HK1254477A1/zh unknown
- 2016-06-22 PL PL16731155.4T patent/PL3313849T3/pl unknown
- 2016-06-22 RU RU2018102361A patent/RU2745430C9/ru active
- 2016-06-22 FI FIEP16731155.4T patent/FI3313849T3/fi active
- 2016-06-22 RS RS20230299A patent/RS64131B1/sr unknown
- 2016-06-22 ES ES16731155T patent/ES2944942T3/es active Active
- 2016-06-22 TW TW109118026A patent/TW202108590A/zh unknown
- 2016-06-22 GE GEAP201614680A patent/GEP20207076B/en unknown
- 2016-06-22 TW TW105119603A patent/TWI715593B/zh active
- 2016-06-22 EA EA201890124A patent/EA036503B1/ru unknown
- 2016-06-22 CA CA2990083A patent/CA2990083C/en active Active
- 2016-06-22 MA MA42231A patent/MA42231B1/fr unknown
- 2016-06-22 HU HUE16731155A patent/HUE061758T2/hu unknown
- 2016-06-22 MY MYPI2017704890A patent/MY190243A/en unknown
- 2016-06-22 LT LTEPPCT/EP2016/064417T patent/LT3313849T/lt unknown
- 2016-06-22 CU CUP2017000162A patent/CU20170162A7/es unknown
- 2016-06-23 AR ARP160101882A patent/AR105104A1/es active IP Right Grant
-
2017
- 2017-12-14 SV SV2017005590A patent/SV2017005590A/es unknown
- 2017-12-14 CO CONC2017/0012845A patent/CO2017012845A2/es unknown
- 2017-12-14 PH PH12017502314A patent/PH12017502314B1/en unknown
- 2017-12-14 IL IL256320A patent/IL256320A/en active IP Right Grant
- 2017-12-15 EC ECIEPI201782825A patent/ECSP17082825A/es unknown
- 2017-12-18 ZA ZA2017/08626A patent/ZA201708626B/en unknown
- 2017-12-20 DO DO2017000304A patent/DOP2017000304A/es unknown
- 2017-12-21 SA SA517390586A patent/SA517390586B1/ar unknown
- 2017-12-21 CL CL2017003316A patent/CL2017003316A1/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017012845A2 (es) | Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| CO2017012832A2 (es) | Compuestos derivados de d-fenilalanina - n - sustituidos con bicíclicos aromáticos, método de preparación de los mismos y composiciones farmacéuticas que los contienen | |
| CO2017012830A2 (es) | Compuestos de n-tieno [2,3-d] pirimidinil-d-fenilalanina, método de preparación de los mismos y composiciones farmacéuticas que los contienen | |
| MX2016012103A (es) | Agonistas del receptor muscarinico. | |
| CO2018002060A2 (es) | Compuestos farmacéuticos | |
| MX2016013689A (es) | Compuestos 4-amino-imidazoquinolina. | |
| BR112018011929A2 (pt) | composto, composição farmacêutica, métodos para tratamento da infecção viral da hepatite c, de carcinoma basocelular, de ceratose actínica, da infecção viral de papiloma genital e da infecção viral de hepatite c, processo para preparação de um composto, e, uso de um composto | |
| NI201600144A (es) | Derivados de quinoxalina utiles como moduladores del fgfr cinasa | |
| MX2020001236A (es) | Compuestos aza biciclicos como agonistas del receptor muscarinico m1. | |
| CR20160006A (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
| DOP2015000157A (es) | Lactamas fusionadas de arilo y heteroarilo | |
| PE20151064A1 (es) | Nuevos derivados tienopirimidina, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| MX2016014547A (es) | Compuestos para tratar atrofia muscular espinal. | |
| CL2016000063A1 (es) | Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen. | |
| CU20160020A7 (es) | Derivados de imidazoquinolinas sustituidas inhibidores de mek para el tratamiento del cáncer | |
| DOP2017000049A (es) | Compuestos tricíclicos que contienen nitrógeno para el tratamiento de la infección por neisseria gonorrhoeae | |
| CO7101239A2 (es) | Composiciones derivadas de la quitosana | |
| ECSP17069696A (es) | Compuestos novedosos | |
| CY1120602T1 (el) | [1,2,4]τριαζολο[4,3-β]πυριδαζινες για χρηση στη θεραπευτικη αντιμετωπιση πολλαπλασιαστικων ασθενειων | |
| CY1122172T1 (el) | Τροποποιητες θειαζολης των a3 υποδοχεων αδενοσινης | |
| CU20160157A7 (es) | Derivados de diheterociclo enlazado a cicloalquilo | |
| BR112017003651A2 (pt) | derivados de isoquinolinona úteis no tratamento de câncer | |
| GT201600190A (es) | Compuestos químicos | |
| UY35600A (es) | "composiciones farmacéuticas que comprenden compuestos derivados de triazolopiridina y métodos para prepararlas" | |
| EA201792502A1 (ru) | Кабазитаксел и его применение для лечения рака |